Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,816 JPY | +0.36% | -1.85% | 0.00% |
May. 06 | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
May. 06 | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.15B | |
+15.65% | 342B | |
+12.06% | 74.21B | |
-8.44% | 67.79B | |
+1.15% | 30.73B | |
+25.53% | 24.07B | |
+9.60% | 14.57B | |
+20.37% | 9.4B | |
-4.07% | 6.66B | |
+3.57% | 4.87B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- Kunyao Group Receives Clinical Trial Approval for FMF Drug